RB Capital Management LLC Takes Position in CME Group Inc. $CME

RB Capital Management LLC acquired a new position in CME Group Inc. (NASDAQ:CME) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 2,703 shares of the financial services provider’s stock, valued at approximately $597,000.

Several other institutional investors have also modified their holdings of CME. Whipplewood Advisors LLC boosted its stake in CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after buying an additional 83 shares in the last quarter. Elkhorn Partners Limited Partnership bought a new stake in CME Group in the fourth quarter worth about $27,000. Hilton Head Capital Partners LLC bought a new stake in CME Group in the fourth quarter worth about $28,000. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in CME Group in the 2nd quarter valued at about $28,000. Finally, Legacy Wealth Managment LLC ID lifted its holdings in CME Group by 191.9% in the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 71 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other news, Director William R. Shepard purchased 325 shares of the business’s stock in a transaction dated Thursday, June 25th. The shares were acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.30% of the stock is currently owned by company insiders.

CME Group Trading Up 1.7%

NASDAQ:CME opened at $285.80 on Friday. The stock has a fifty day simple moving average of $253.80 and a 200 day simple moving average of $279.13. The firm has a market capitalization of $102.77 billion, a price-to-earnings ratio of 24.24, a price-to-earnings-growth ratio of 3.34 and a beta of 0.23. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the previous year, the company earned $2.96 EPS. The business’s revenue for the quarter was up .8% compared to the same quarter last year. Sell-side analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is 44.11%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on CME. The Goldman Sachs Group lowered their price objective on shares of CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research note on Tuesday, June 30th. JPMorgan Chase & Co. increased their target price on shares of CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research note on Thursday, July 23rd. Piper Sandler reduced their target price on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a report on Wednesday, July 15th. Wall Street Zen upgraded shares of CME Group from a “strong sell” rating to a “sell” rating in a research report on Saturday. Finally, Bank of America upped their price target on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a report on Thursday, July 23rd. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $288.56.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.